Abstract:The study aimed to optimize qPCR reactions using oligonucleotides from the first Brazilian molecular diagnostic kit for leprosy on a portable platform (Q3-Plus). In addition, we sought to develop a simplified protocol for DNA extraction that met point-of-care criteria. During optimization on the Q3-Plus, optical parameters, thresholds, and cutoffs for the 16S rRNA and RLEP targets of M . leprae were established using synthetic DNA, purified DNA from M . leprae , and pre-characterized clinical samples. For the simplified extraction protocol, different lysis solutions were evaluated using chaotropic agents, and purification was carried out by transferring the lysed material to FTA cards. The complete protocol (simplified extraction + qPCR on the portable platform) was then evaluated with pre-characterized clinical skin biopsy samples and compared with standard equipment (QuantStudio-5). LOD 95% for the optimized reactions was 113.31 genome-equivalents/μL for 16S rRNA and 17.70 genome-equivalents/μL for RLEP. Among the lysis solutions, the best-performing was composed of urea (2 M), which provided good dissolution of the skin fragment and a lower Ct value, indicating higher concentrations of DNA. The complete technological solution showed a sensitivity of 52% in reactions. Our results highlight the need for additional optimization to deal with paucibacillary samples, but also demonstrate the feasibility of the portable platform for the qPCR detection of M . leprae DNA in low infrastructure settings. The diagnosis of tropical or neglected infectious diseases, such as leprosy, is highly dependent on techniques that are not very sensitive or very laborious, such as optical microscopy or culture. More sensitive and specific molecular tests are only available in urban centers, where there is a specialized workforce and adequate infrastructure. However, a large portion of the population does not have access to such medical services, either due to financial or distance issues. Thus, performing diagnostic tests at the point of care (POC) provides agility in diagnosis, avoiding the need for patients to travel to medical centers or transport biological samples to clinical analysis centers, ensuring that this population has access to diagnostic tests, even in remote areas or with poor infrastructure. In this work, we optimize and validate, on a laboratory scale, simplified versions of all the procedures necessary to perform molecular tests, from collection and DNA extraction to the detection of genomic targets using portable qPCR equipment. The results presented here are the basis of a novel tool with potential to increase a leprosy screening test in remote areas, facilitating the active search of positive cases and monitoring by health authorities responsible for underserved populations.

Advanced DNA–Gold Biointerface for PCR‐Free Molecular Detection of Leishmania infantum

Electrical detection of oligonucleotide using an aggregate of gold nanoparticles as a conductive tag.

Instrument-Free Point-of-Care Diagnostic for Leishmania Parasites

Rapid and Highly Sensitive Detection of Leishmania by Combining Recombinase Polymerase Amplification and Solution-Processed Oxide Thin-Film Transistor Technology

Duplex qPCR for Leishmania species identification using lesion imprint on filter paper

Rapid detection, quantification and speciation of Leishmania using real-time PCR and DNA sequencing at the rRNA Internal Transcribed Spacer 2

Visual and Rapid Detection of Leptospira interrogans Using Multiple Cross-Displacement Amplification Coupled with Nanoparticle-Based Lateral Flow Biosensor.

Portable smartphone-based molecular test for rapid detection of Leishmania spp.

Development of nucleic acid lateral flow immunoassay for duplex detection of Leishmania martiniquensis and Leishmania orientalis in asymptomatic patients with HIV

Validation of the performance of a point of care molecular test for leprosy: From a simplified DNA extraction protocol to a portable qPCR

Application of Quantitative PCR in the Diagnosis and Evaluating Treatment Efficacy of Leishmaniasis

Coupling Nanotechnology to Optical Affinity Sensing: The Case of Surface Plasmon Resonance Imaging for DNA Detection

Performance evaluation of nine reference centers for effective surveillance of -infected Phlebotomine sand flies and basis for technical recommendations

Development of species-specific multiplex PCR for Leishmania identification

DNA-Directed Protein Anchoring on Oligo/Alkanethiol-Coated Gold Nanoparticles: A Versatile Platform for Biosensing Applications

Q3 lab-on-chip real-time PCR for the diagnosis of Leishmania infantum infection in dogs

Multi-Channel Funnel Adapted Sensing Tube (MFAST) for the Simple and Duplex Detection of Parasites

Lessons learned from BaBar silicon vertex tracker, limits and future perspectives of the detector

Detection and identification of Leishmania spp.: application of two hsp70-based PCR-RFLP protocols to clinical samples from the New World

An integrated biosensor platform for extraction and detection of nucleic acids